Gland Pharma Ltd., incorporated in the year 1978, is a Small Cap company (having a market cap of Rs 24,029.86 Crore) operating in Pharmaceuticals sector. Gland Pharma Ltd. key Products/Revenue ...

Introduction: Surgery and radiotherapy are key cancer treatments and the leading causes of damage to the lymphatics, a vascular network critical to fluid homeostasis and immunity. The clinical ...

Among the different ion channel families, the Transient Receptor Potential (TRP) family stands out in the context of breast cancer since several members have been proposed as prognostic markers in ...